[CRVS] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 7.73%
YoY- 59.54%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -40,217 -6,000 -14,831 -10,673 -9,796 -11,004 -10,498 25.06%
Tax 0 -425 -225 -1,604 0 -186 0 -
NP -40,217 -6,000 -14,831 -10,673 -9,796 -11,004 -10,498 25.06%
Tax Rate - - - - - - - -
Total Cost 40,217 6,000 14,831 10,673 9,796 11,004 10,498 25.06%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.60 -0.12 -0.32 -0.24 -0.33 -0.37 -0.36 8.87%
EPS Diluted -0.60 -0.12 -0.32 -0.24 -0.33 -0.37 -0.36 8.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.